WMSA
ZYME icon

Weiss Multi-Strategy Advisers’s Zymeworks ZYME Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,386
Closed -$285K – 812
2021
Q4 		$285K Sell
17,386
-71
-0.4% -$1.48K 0.01% 592
2021
Q3 		$507K Buy
17,457
+380
+2% +$12.6K 0.01% 552
2021
Q2 		$592K Buy
17,077
+612
+4% +$19.4K 0.01% 541
2021
Q1 		$520K Sell
16,465
-3,630
-18% -$148K 0.01% 544
2020
Q4 		$950K Sell
20,095
-231
-1% -$10.7K 0.02% 496
2020
Q3 		$947K Buy
20,326
+227
+1% +$7.79K 0.03% 430
2020
Q2 		$725K Buy
20,099
+838
+4% +$30.9K 0.02% 443
2020
Q1 		$683K Buy
+19,261
New +$788K 0.03% 327

Other funds holding ZYME

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ZYME Position: Q1 2022 in Review

Weiss Multi-Strategy Advisers sold out of Zymeworks (ZYME) in Q1 2022, closing a stake of 17,386 shares — an estimated $285K sold.

Weiss Multi-Strategy Advisers first reported a position in ZYME in Q1 2020 and held it in 8 quarters. The position peaked at $950K in Q4 2020. 120 funds tracked by Wall St. Rank hold ZYME as of Q1 2022.

  • Weiss Multi-Strategy Advisers reported no remaining Zymeworks position as of Q1 2022 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 17,386 Zymeworks shares in Q1 2022, an estimated $285K.
  • Weiss Multi-Strategy Advisers first reported a position in Zymeworks in Q1 2020 and held it in 8 quarters.
  • Weiss Multi-Strategy Advisers's Zymeworks position peaked at $950K in Q4 2020.
  • 120 funds tracked by Wall St. Rank held Zymeworks as of Q1 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2022, filed 16 May 2022.